scholarly journals Myocardial Ischemic Syndromes, Heart Failure Syndromes, Electrocardiographic Abnormalities, Arrhythmic Syndromes and Angiographic Diagnosis of Coronary Artery Spasm: Literature Review

2020 ◽  
Vol 17 (8) ◽  
pp. 1071-1082
Author(s):  
Ming-Yow Hung ◽  
Nicholas G. Kounis ◽  
Meng-Ying Lu ◽  
Patrick Hu
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Literature Review ◽  
Coronary Artery Spasm ◽  
Electrocardiographic Abnormalities ◽  
Angiographic Diagnosis

scholarly journals Neostigmine induced coronary artery spasm: A case report and literature review

2017 ◽  
Vol 33 (3) ◽  
pp. 402 ◽  
Author(s):  
Alexander Ioscovich ◽  
Shimon Kolker ◽  
Dan Tzivoni ◽  
David Rosenmann ◽  
Shmuel Meyler
Keyword(s):  
Case Report ◽  
Coronary Artery ◽  
Literature Review ◽  
Coronary Artery Spasm

scholarly journals Post-valvular surgery multi-vessel coronary artery spasm — A literature review

2016 ◽  
Vol 10 ◽  
pp. 32-38
Author(s):  
Francesco Formica ◽  
Oluwaseun Adebayo Bamodu ◽  
Serena Mariani ◽  
Giovanni Paolini
Keyword(s):  
Coronary Artery ◽  
Literature Review ◽  
Coronary Artery Spasm ◽  
Valvular Surgery ◽  
Vessel Coronary Artery

scholarly journals Takotsubo cardiomyopathy: Report of the first case series in Serbia and review of the literature

2010 ◽  
Vol 63 (1-2) ◽  
pp. 75-81 ◽  
Author(s):  
Biljana Putnikovic ◽  
Vojkan Cvorovic ◽  
Milos Panic ◽  
Predrag Milicevic ◽  
Gordana Vojinovic-Maglic ◽  
...  
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Acute Heart Failure ◽  
Takotsubo Cardiomyopathy ◽  
Coronary Artery Spasm ◽  
Case Series ◽  
Left Ventricular ◽  
Coronary Microvascular Dysfunction ◽  
Review Of The Literature ◽  
First Case

Introduction. Takotsubo cardiomyopathy is a relatively novel cardiac syndrome that is characterized by transient left ventricular asynergy involving apical and mid-ventricular segments. Epidemiology and pathophisiology. It occurs predominantly in elderly women in the absence of obstructive coronary artery disease and is usually associated with severe emotional or physical stress. This syndrome is manifested with chest pain, electrocardiographic changes that mimic acute myocardial infarction, and minimal myocardial enzy?matic release. Several different mechanisms have been proposed: coronary artery spasm, dynamic left ventricular outflow/intracavitary obstruction, coronary microvascular dysfunction and direct catecholamine-mediated cardiomyocite injury. Therapy and prognosis. Complete recovery usually occurs after dramatic presentation, frequently complicated with acute heart failure. Therapy is empiric and directed towards supportive measures against cardiogenic shock, acute heart failure, dysrhythmias. In-hospital mortality rate is less than 1%, but long-term prognosis is still unknown. In addition to the review of the literature on takotsubo cardiomyopathy, we present the first series of patients with this syndrome detected in Clinical Hospital Center Zemun.

scholarly journals The Prevalence of Silent Coronary Artery Spasm in Patient with Chronic Heart Failure

2016 ◽  
Vol 22 (9) ◽  
pp. S172-S173
Author(s):  
Shingo Yoshioka ◽  
Takashi Shimozato ◽  
Hirotaka Ohtake ◽  
Miyuki Ando ◽  
Ryosuke Kametani
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Chronic Heart Failure ◽  
Coronary Artery Spasm

Kanker als hartenbreker: cardio-oncologie, meer dan alleen hartfalen?

2021 ◽  
Author(s):  
B. VON KEMP ◽  
S. DROOGMANS ◽  
B. COSYNS
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Arterial Hypertension ◽  
Cancer Treatment ◽  
Kinase Inhibitors ◽  
Plaque Rupture ◽  
Checkpoint Inhibitors ◽  
Coronary Artery Spasm ◽  
Added Value ◽  
Type I

Cancer treatment: it can break your heart … As cancer survival is improving, the risk for developing cardiovascular disease (CVD) from cancer treatment increases. Cancer patients and survivors are indeed susceptible for the development of cancer treatment-induced heart disease, especially if pre-existing CVD or cardiovascular risk factors (arterial hypertension, hypercholesterolemia, diabetes mellitus, smoking) are present. Every treatment class has a particular toxicity profile that requires dedicated attention. The best studied form of cardiotoxicity is anthracycline-induced heart failure ( toxicity type I, dose-dependent and irreversible). Fluoropyrimidines may induce coronary artery spasm or plaque rupture, trastuzumab may cause heart failure ( toxicity type II, usually reversible and dose-independent), and antiangiogenic treatments induce arterial hypertension. Tyrosine kinase inhibitors can cause heart failure, hypertension and QT-prolongation, and immune checkpoint inhibitors may cause life-threatening myocarditis, typically short after initiating treatment. Radiotherapy-induced valvulopathy and coronary artery disease typically manifest late (> 10 years) after treatment termination. Intensive research is being conducted in the field of cardioprotection, and a multidisciplinary approach with dedicated expertise on the topic is required when decisions about (dis-)continuation of potentially life-saving cancer treatments are to be made. A dedicated cardio-oncology clinic answers this need and is an added value for both patient and oncologist.

scholarly journals Heart Failure with Silent Coronary Artery Spasm Exhibiting Microscopic Focal Myocardial Necrosis and Amyloid-Deposition

2004 ◽  
Vol 43 (3) ◽  
pp. 199-203 ◽  
Author(s):  
Satoru SUZUKI ◽  
Seigo SUGIYAMA ◽  
Hiroki USUKU ◽  
Nobutaka HIRAI ◽  
Koichi KAIKITA ◽  
...  
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Coronary Artery Spasm ◽  
Myocardial Necrosis ◽  
Amyloid Deposition
Sign in / Sign up

Export Citation Format

Share Document